ARTELO BIOSCIENCES, INC. Class of Warrant or Right, Outstanding
ARTELO BIOSCIENCES, INC. (ARTL) had Class of Warrant or Right, Outstanding of 4.43 billion shares as of 2021-12-31, per its 10-KT filed 2022-03-21.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2022-03-21
- 2021-12-31: Class of Warrant or Right, Outstanding 4.43B shares.
- 2021-08-31: Class of Warrant or Right, Outstanding 4.43B shares.
- 2021-05-31: Class of Warrant or Right, Outstanding 4.43M shares.
- 2021-02-28: Class of Warrant or Right, Outstanding 5.35M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2021-12-31 | 4.43B shares 10-KT · filed 2022-03-21 | |
| 2021-08-31 | 4.43B shares 10-KT · filed 2022-03-21 | |
| 2021-05-31 | 4.43M shares 10-Q · filed 2021-07-12 | |
| 2021-02-28 | 5.35M shares 10-Q · filed 2021-04-13 | |
| 2020-11-30 | 12.45M shares 10-Q · filed 2021-01-14 | |
| 2020-08-31 | 2.33B shares 10-KT · filed 2022-03-21 | 2.33M shares 10-K · filed 2020-11-04 |
| 2020-05-31 | 2.33M shares 10-Q · filed 2020-07-13 | |
| 2020-02-29 | 2.33M shares 10-Q · filed 2020-04-13 | |
| 2019-11-30 | 2.33M shares 10-Q · filed 2020-01-14 | |
| 2019-08-31 | 2.33B shares 10-K · filed 2021-11-29 | 2.33M shares 10-K · filed 2019-11-25 |
| 2019-05-31 | 732.35K shares 10-Q · filed 2019-07-15 | |
| 2019-02-28 | 5.64M shares 10-Q · filed 2019-04-15 | |
| 2018-08-31 | 495.31K shares 10-K · filed 2020-11-04 | 3.96M shares 10-Q · filed 2019-04-15 |
| 2017-08-31 | 240.92K shares 10-K/A · filed 2019-12-18 | |
| 2017-05-31 | 575.00K shares 10-Q · filed 2017-07-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |